VXRT - Vaxart's Coronavirus Stock Bump Is Unlikely To Continue So Exit Now Or Be Very Long
Vaxart, Inc (VXRT) is a clinical stage biotech company developing vaccines taken orally by tablet instead of by injection. Vaxart is currently working with Emergent BioSolutions (EBS) to develop a potential coronavirus (Covid-19) vaccine. A clinical study is scheduled to begin sometime in the second half of 2020.
Many companies are racing to develop a coronavirus vaccine. Seeking Alpha has noted some companies are more credible than others, without opining about who falls into which category. Previously, I considered iBio (IBIO) and put it in the non-credible category. Vaxart is not the worst